Pictet Asset Management Sa Bellus Health Inc. Transaction History

Pictet Asset Management Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$7.14 - $8.53 $2.74 Million - $3.27 Million	383,534 Added 5.73%	7,072,143 $50.9 Million
Q4 2022 Feb 13, 2023	SELL	$8.22 - $10.76 $13.8 Million - $18 Million	-1,674,685 Reduced 20.02%	6,688,609 $54.7 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $39.5 Million - $53 Million	4,414,746 Added 111.81%	8,363,294 $88.7 Million
Q2 2022 Aug 09, 2022	BUY	$6.46 - $10.02 $25.5 Million - $39.6 Million	3,948,548 New	3,948,548 $36.3 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.